Genome-wide identification of virulence genes in Acinetobacter baumannii in vivo

鲍曼不动杆菌体内毒力基因的全基因组鉴定

基本信息

  • 批准号:
    8824871
  • 负责人:
  • 金额:
    $ 23.33万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-03-20 至 2017-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Acinetobacter baumannii, a Gram-negative bacterium, has emerged as an important opportunistic pathogen that poses a significant public health risk in the United States. Clinically, A. baumannii is emerging as a leading nosocomial pathogen, particularly in intensive care units specializing in respiratory care, trauma and burns. Despite having the complete genome sequences for three strains of A. baumannii, the identity of most genes that are essential for pathogenesis in a mammalian host is not known. We propose to identify which of the nearly 4000 bacterial genes are essential for survival in a mammalian host and to demonstrate the necessity for each gene during experimentally induced bacteremia. The result will represent a major step forward in understanding the pathobiology of A. baumannii infections and for devising strategies to treat these infections or vaccinate against their occurrence. Our long-term goal is to systematically establish a molecular model of pathogenesis for A. baumannii infection. The objective of this application is to identify all genes essential to establish infection within a mammalian host. Based on a successful pilot experiment with 109,000 mutant of A. baumannii ATCC17978 in a murine model of bacteremia, our central hypothesis is that genes of A. baumannii essential for development of bacteremia can be determined by combining global transposon mutagenesis, a murine model of infection, and high throughput sequencing. Our rationale for conducting this work is to establish a framework that will direct detailed mechanistic investigations of A. baumannii pathogenesis in compromised patients. Using a saturating transposon library of A. baumannii mutants, the animal model of bacteremia, and high- throughput DNA sequencing, we will accomplish the following specific aims: 1) identify virulence genes essential for A. baumannii to colonize and disseminate within a mammalian host; and 2) confirm A. baumannii virulence genes that contribute most significantly to colonization and dissemination in the murine model using defined mutations. This contribution will be significant because, in these comprehensive and unbiased experiments, we will determine for the first time the complete A. baumannii virulence gene set for two strains during a mammalian infection. This proposal should be considered innovative as it applies transposon-directed insertion-site sequencing (TraDIS) for genome-wide identification of A. baumannii virulence genes using a forward-genetic screen in a relevant animal model of infection.
描述(由申请人提供):鲍曼不动杆菌是一种革兰氏阴性菌,已成为一种重要的机会性病原体,在美国构成重大的公共卫生风险。在临床上,鲍曼不动杆菌正在成为一种主要的医院病原体,特别是在专门从事呼吸护理、创伤和烧伤的重症监护病房。尽管有三个鲍曼不动杆菌菌株的完整基因组序列,但大多数对哺乳动物宿主发病至关重要的基因的身份尚不清楚。我们打算从近4000个细菌基因中找出哪些是哺乳动物宿主生存所必需的,并在实验诱导的菌血症中证明每个基因的必要性。这一结果将在理解鲍曼不动杆菌感染的病理生物学和制定治疗这些感染的策略或预防其发生的疫苗方面迈出重要一步。我们的长期目标是系统地建立鲍曼不动杆菌感染发病机制的分子模型。此应用程序的目的是识别所有基因

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The lytic transglycosylase MltB connects membrane homeostasis and in vivo fitness of Acinetobacter baumannii.
  • DOI:
    10.1111/mmi.14000
  • 发表时间:
    2018-09
  • 期刊:
  • 影响因子:
    3.6
  • 作者:
    Crépin S;Ottosen EN;Peters K;Smith SN;Himpsl SD;Vollmer W;Mobley HLT
  • 通讯作者:
    Mobley HLT
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HARRY L. MOBLEY其他文献

HARRY L. MOBLEY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HARRY L. MOBLEY', 18)}}的其他基金

E. coli virulence gene expression during clinical UTIs in women
女性临床尿路感染期间大肠杆菌毒力基因的表达
  • 批准号:
    10657698
  • 财政年份:
    2022
  • 资助金额:
    $ 23.33万
  • 项目类别:
E. coli virulence gene expression during clinical UTIs in women
女性临床尿路感染期间大肠杆菌毒力基因的表达
  • 批准号:
    10515444
  • 财政年份:
    2022
  • 资助金额:
    $ 23.33万
  • 项目类别:
Reciprocal regulation of persistence in the environment and pathogenesis of Acinetobacter baumannii
鲍曼不动杆菌环境持久性和发病机制的相互调节
  • 批准号:
    10054498
  • 财政年份:
    2020
  • 资助金额:
    $ 23.33万
  • 项目类别:
Reciprocal regulation of persistence in the environment and pathogenesis of Acinetobacter baumannii
鲍曼不动杆菌环境持久性和发病机制的相互调节
  • 批准号:
    10171557
  • 财政年份:
    2020
  • 资助金额:
    $ 23.33万
  • 项目类别:
Vaccine to prevent E. coli urinary tract infection
预防大肠杆菌尿路感染的疫苗
  • 批准号:
    9186483
  • 财政年份:
    2015
  • 资助金额:
    $ 23.33万
  • 项目类别:
Vaccine to prevent E. coli urinary tract infection
预防大肠杆菌尿路感染的疫苗
  • 批准号:
    9027113
  • 财政年份:
    2015
  • 资助金额:
    $ 23.33万
  • 项目类别:
Vaccine to prevent E. coli urinary tract infection
预防大肠杆菌尿路感染的疫苗
  • 批准号:
    10464436
  • 财政年份:
    2015
  • 资助金额:
    $ 23.33万
  • 项目类别:
Genome-wide identification of virulence genes in Acinetobacter baumannii in vivo
鲍曼不动杆菌体内毒力基因的全基因组鉴定
  • 批准号:
    8699488
  • 财政年份:
    2014
  • 资助金额:
    $ 23.33万
  • 项目类别:
Small molecule inhibitors of bacterial iron acquisition systems
细菌铁获取系统的小分子抑制剂
  • 批准号:
    8699191
  • 财政年份:
    2013
  • 资助金额:
    $ 23.33万
  • 项目类别:
Small molecule inhibitors of bacterial iron acquisition systems
细菌铁获取系统的小分子抑制剂
  • 批准号:
    8891411
  • 财政年份:
    2013
  • 资助金额:
    $ 23.33万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 23.33万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 23.33万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.33万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.33万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 23.33万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.33万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 23.33万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 23.33万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 23.33万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.33万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了